Society of Hospital Medicine SHM
HomeLogoutCareer CenterSHM CommunityQI Resource Rooms 
 
sitemap contact questions
Advanced Search
About SHM
Membership
Education
Quality Improvement
 
QI Current Initiatives and Training Opportunities
 
QI Primer
 
QI Clinical Tools
 
QI Resource Rooms
            
Practice Resources
Advocacy
Events
Publications
News and Media
Join SHM
SHM Store


Exchange Information Implementation Guide Professional Development Resource Room Project Team Main Resource Room Home Acute Coronary Syndrome Resource Room

Medication: Safety & Polypharmacy

By Chad Whelan, MD

Patients admitted with ACS often require complex medication regimens throughout their hospitalization and while transitioning to discharge. In addition to the medications that are primarily for ACS, these patients will often have comorbid conditions such as diabetes, hypertension, or congestive heart failure that all require several medications independently. In addition, many patients admitted with ACS are elderly, and the risk of side effects and the dangers of polypharmacy are increased in the elderly. Thus, the safe use of these complex regimens will be an important part of your standardization of care.

There are several key steps to consider to maximize medication safety and minimize unnecessary polypharmacy. These can include:

  • Use a standard approach to verify medication reconciliation as the patient moves throughout the hospitalization, from ED to DC.
  • Develop standard protocols for drug monitoring when appropriate, such as when using standard heparin nomograms and automated platelet checking for patients on heparin.
  • Maintain appropriate drug–drug interaction checking, especially for those drugs likely to be used in these patients, such as beta-blockers and negative chronotropic calcium channel blockers or ACE I and spironolactone.
  • Use the medication reconciliation process as an opportunity to discontinue medications no longer required.
  • Assure that appropriate monitoring systems are in place for patients being discharged on medications that require such monitoring.
  • Provide a complete list of medication and indications to the patient and the physicians seen in follow-up. 

Providing patients with written information about their new medications can be very useful. See the Clinical Tools section for resources you might be able to use to provide your patients with this type of information.

 

 

 

ACS Resource Room Project Team
This resource room is supported in part by an educational grant from the Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership.

Disclaimer
The Acute Coronary Syndrome (ACS) Resource Room is an online resource for visitors to the Society of Hospital Medicine's website. All content and links have been reviewed by Acute Coronary Syndrome Resource Room Project Team, however the Society of Hospital Medicine does not exercise any editorial control over content associated with the external links that have been made available via this website.
About SHM  Membership  Education  Quality Improvement  Practice Resources  Advocacy  Events  Publications
News and Media  Join SHM  SHM Store  Home  Login/Logout  Career Center  SHM Community  QI Resource Rooms  

©2008 Society of Hospital Medicine (SHM). All rights reserved.

SHM National Office: 1500 Spring Garden, Suite 501, Philadelphia, PA 19130
Phone: 800.843.3360 | Fax: 267.702.2690 | Email: webmaster@hospitalmedicine.org.
Report a problem with this site.